Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 547-549, 2012.
Artículo en Chino | WPRIM | ID: wpr-746758

RESUMEN

OBJECTIVE@#To investigate the behavior difference of allergic rhinitis with adenoid hypertrophy between study group and control group.@*METHOD@#One hundred and seventeen children diagnosed as allergic rhinitis with adenoid hypertrophy were enrolled in our study were divided into study group and control group. Forty-two children treated with local steroid nasal spray for two to three months and antihistamine were control group. Seventy-five children treated with endoscopic adenoidectomy and drug treatment were study group; All children' parents were inquired for their clinical presentation.@*RESULT@#No distinctive differences were found between the two groups (P > 0.05) in adenoid hypertrophy, accompanying nasal problems and clinical questionnaire scoring. Significant statistical distinction were found (P < 0.05) in snoring, sleep disturbance and frequent arousal, nasal obstructive moth-breathing, and recurrent respiratory tract infection between the two groups after three-month follow up.@*CONCLUSION@#Endoscopic adenoidectomy should be taken into account for allergic rhinitis with adenoid hypertrophy in children. Adenoidectomy would be useful for the improvement of behavior symptoms.


Asunto(s)
Niño , Femenino , Humanos , Masculino , Adenoidectomía , Métodos , Tonsila Faríngea , Patología , Antialérgicos , Estudios de Casos y Controles , Terapia Combinada , Endoscopía , Antagonistas de los Receptores Histamínicos H1 , Hipertrofia , Terapéutica , Rinitis Alérgica , Terapéutica , Esteroides
2.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 558-560, 2009.
Artículo en Chino | WPRIM | ID: wpr-748700

RESUMEN

OBJECTIVE@#To investigate the effect of several traditional Chinese medicine formula therapies on proliferation of nasopharyngeal carcinoma cell line HNE1.@*METHOD@#The inhibition effect of medicine serums of Qi-Boosting Toxin-Resolving granule on proliferation of NPC cell line HNE1 in vitro was observed by MTT assay.@*RESULT@#The rates of survival cells in Qi-Boosting Toxin-Resolving decoction group and Toxin-Resolving group were the lowest after 48 hours treatment, while Qi-Boosting group, yin-nourishing group, residual-component group medicine serums had the most obvious effects on the rates of survival cells at 72 hours. The inhibition ratio of 15% Qi-Boosting Toxin-Resolving granule medicine serums was 67.68%.@*CONCLUSION@#The result of MTT assay showed that cell proliferation was significantly inhibited by Qi-Boosting Toxin-Resolving granule and its separate composes medicine serums. Qi-Boosting Toxin-Resolving granule had the most significantly specific effects. The effects were correlated with serum concentration and treatment time of Qi-Boosting Toxin-Resolving granule and its separate composes medicine.


Asunto(s)
Animales , Humanos , Ratas , Línea Celular Tumoral , Proliferación Celular , Medicamentos Herbarios Chinos , Farmacología , Medicina Tradicional China , Neoplasias Nasofaríngeas , Ratas Sprague-Dawley , Suero
3.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 146-148, 2007.
Artículo en Chino | WPRIM | ID: wpr-748858

RESUMEN

OBJECTIVE@#To investigate the efficacy of round window catheter placement with dexamethasone perfusion for 13 patients with intractable sudden sensorineural hearing loss (SSNHL).@*METHOD@#Dexamethasone (2.5 mg) was perfused transtympanically through round window catheter by Micro-infusion pump. The perfusion was taken twice a day and continued for an hour each time, for a total of 7 days.@*RESULT@#Thirteen patients have been followed up for 1 month. Five of them (38.5%) were demonstrated a 17-54 dB improvement in pure-tone threshold average (PTA). The other 8 patients (61.5%) had no effect.@*CONCLUSION@#Round window catheter placement with dexamethasone perfusion is a cost-effective and useful treatment for SSNHL patients who had no effect through conventional therapy, although hearing thresholds of these patients had hardly improved to normal levels.


Asunto(s)
Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Cateterismo , Dexametasona , Usos Terapéuticos , Pérdida Auditiva Sensorineural , Quimioterapia , Pérdida Auditiva Súbita , Quimioterapia , Ventana Redonda
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA